Cyanidin-3-O-glucoside, when combined with cisplatin in cervical cancer cells, downregulated Nrf2 and its downstream antioxidant proteins, increasing sensitivity to chemotherapy 109. This evidence concerns the gene NFE2L2 and cervical cancer.